Oregon Clinical and Translational Research Institute Quality Assurance and Quality Control Project

俄勒冈临床和转化研究所质量保证和质量控制项目

• 批准号: 10158949
• 负责人: David H Ellison
• 金额: $ 14.93万
• 依托单位: OREGON HEALTH & SCIENCE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-09-02 至 2022-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10158949
• 关键词: Address; Administrative Personnel; Attention; Attitude; Award; Biomedical Research; Budgets; Businesses; Clinical; Clinical Research; Clinical Sciences; Clinical Trials; Collaborations; Communities; Complex; Disease; Effectiveness; Evaluation; Event; Fostering; Funding Opportunities; Future; Goals; Health Sciences; Home environment; Human Resources; Informatics; Institutes; Institution; Investments; Knowledge; Lead; Leadership; Learning; Location; Maintenance; Measures; Monitor; Oregon; Outcome Measure; Patient Recruitments; Periodicity; Persons; Positioning Attribute; Principal Investigator; Process; Quality Control; Reporting; Research; Research Institute; Research Personnel; Research Support; Resources; Science; Services; Structure; Support System; System; Testing; Trainers Training; Training; Translational Research; Universities; clinical care; cost; improved; innovation; next generation; programs; quality assurance; skills; success; tool; translational scientist

The Oregon Clinical and Translational Research Institute (OCTRI) has been accelerating research at Oregon Health & Science University since 2006. Its many highly functional programs assist investigators and trainees by providing diverse services. Here, we propose that OCTRI will transition to retain our strengths, but also become a key hub in the national network, by focusing on five crosscutting aims. These align closely with the goals of the Funding Opportunity Announcement, and the goals outlined by NCATS for the CTSA program in an ideal state. OCTRI's overall aims are to: Overall Aim 1: Catalyze Clinical and Translational Research. Overall Aim 2: Enhance Partnerships with Communities. Overall Aim 3: Foster and Support Scientific Collaboration. Overall Aim 4: Expand the Translational Workforce for the 21st Century. Overall Aim 5: Cultivate Innovation in Research. We have organized a highly functional leadership structure to enable us to meet these goals, and will seek the guidance of several advisory groups. We will catalyze research by developing and supporting new informatics approaches that both integrate the clinical care enterprise with the research enterprise and facilitate the recruitment of patients into clinical trials, locally and across the CTSA network. We will engage diverse stakeholders in the translational research process, by partnering with OHSU investigators, community coalitions, and business enterprises. We will foster team science through local awards to trainees and to emerging investigators. We will partner with regional institutions to foster community-engaged research, to enhance the diversity of trainees, and to provide opportunities in biomedical research not available at other institutions. We will train clinical and translational scientists and research staff for the next generation, by focusing on the skills and attitudes necessary for research in the future. At all steps, we will measure outcomes and, when necessary, “turn the curve.”

俄勒冈州临床和转化研究所（OCTRI）一直在加速俄勒冈州的研究 自2006年以来的健康与科学大学。其许多高度功能的计划协助调查人员和受训者 通过提供多种服务。在这里，我们建议OCTRI过渡以保持我们的优势，但也将 通过专注于五个横切目标，成为国家网络中的关键枢纽。这些与 资助机会公告的目标以及NCAT概述的CTSA计划的目标 理想状态。 OCTRI的总体目的是： 总体目标1：催化临床和转化研究。 总体目标2：增强与社区的伙伴关系。 总体目标3：促进和支持科学合作。 总体目标4：扩大21世纪的转化劳动力。 总体目标5：研究研究中的创新。 我们已经组织了高度功能的领导结构，以使我们能够实现这些目标，并将寻求 几个咨询小组的指导。我们将通过开发和支持新信息来促进研究 既将临床护理企业与研究企业融合在一起的方法，并促进 将患者招募到本地和CTSA网络中的临床试验中。我们将吸引潜水 转化研究过程中的利益相关者，与OHSU调查人员合作，社区 联盟和商业企业。我们将通过向学员的本地奖项培养团队​​科学，并 新兴调查员。我们将与区域机构合作，以促进社区参与研究，以 提高学员的多样性，并提供其他其他生物医学研究的机会 机构。我们将培训下一代的临床和翻译科学家和研究人员， 专注于未来研究所需的技能和参加。在所有步骤中，我们将衡量结果 而且，必要时，“转弯曲线”。